Emend and Doxycycline hyclate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Emend (aprepitant) and Doxycycline hyclate (doxycycline hyclate). Common drug interactions include blister among females and cytokine release syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Emend and Doxycycline hyclate. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.
What is Emend?
Emend has active ingredients of aprepitant. It is often used in nausea. eHealthMe is studying from 13,741 Emend users. Check the latest studies of Emend.
What is Doxycycline hyclate?
Doxycycline hyclate has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 17,880 Doxycycline hyclate users. Check the latest studies of Doxycycline hyclate.
56 people who take Emend and Doxycycline hyclate together, and have interactions are studied.

What are the common drug interactions of Emend and Doxycycline Hyclate, by gender? *:
female:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Hand deformity
- Hepatic enzyme increased
- Joint swelling
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Fatigue (feeling of tiredness)
- Glossodynia (a burning or painful sensation in the tongue)
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Pericarditis (inflammation of the pericardium)
male:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Mucosal inflammation (infection of mucous membrane)
- Neutropenia (an abnormally low number of neutrophils)
- Prostate cancer
- Pyrexia (fever)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Corneal abrasion (loss of the surface of cornea)
What are the common drug interactions of Emend and Doxycycline Hyclate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Alopecia (absence of hair from areas of the body)
- Grip strength decreased
- Ill-defined disorder
- Anti-cyclic citrullinated peptide antibody positive
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Hand deformity
- Hepatic enzyme increased
- Joint swelling
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Fatigue (feeling of tiredness)
50-59:
- Lipase increased
- Pancreatitis acute (sudden inflammation of pancreas)
60+:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Mucosal inflammation (infection of mucous membrane)
- Neutropenia (an abnormally low number of neutrophils)
- Prostate cancer
- Pyrexia (fever)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Corneal abrasion (loss of the surface of cornea)
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 50 people, 89.29%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 50 people, 89.29%
- Psoriasis (immune-mediated disease that affects the skin): 33 people, 58.93%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 29 people, 51.79%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 24 people, 42.86%
- Inflammation: 21 people, 37.50%
- Synovitis (inflammation of the synovial membrane): 20 people, 35.71%
- Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 19 people, 33.93%
- Pain: 19 people, 33.93%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 19 people, 33.93%
* Approximation only. Some reports may have incomplete information.
Do you take Emend and Doxycycline hyclate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Emend (13,741 reports)
- Doxycycline hyclate (17,880 reports)
Browse all drug interactions of Emend and Doxycycline hyclate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Emend:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Doxycycline hyclate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Emend and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Doxycycline hyclate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on aprepitant and doxycycline hyclate (the active ingredients of Emend and Doxycycline hyclate, respectively), and Emend and Doxycycline hyclate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Augmentin '125' cause Blood Alkaline Phosphatase Increased? - 8 seconds ago
- Pulmonary Tuberculosis Aggravated and Fever - 9 seconds ago
- Drug interactions of Flumazenil and Xyrem - 22 seconds ago
- Could Perindopril Erbumine cause Weakness? - 26 seconds ago
- Could Skelaxin cause Diabetic Ketoacidosis? - 27 seconds ago
- Lexapro and Hypoglycemia for Women aged 20-29 - 38 seconds ago
- Lexapro and Hypoglycaemia for Women aged 20-29 - 38 seconds ago
- Lexapro and Low Blood Sugar for Women aged 20-29 - 39 seconds ago
- Lexapro and Insulin Shock for Women aged 20-29 - 39 seconds ago
- Speech Impairment (Adult) and drugs of ingredients of efavirenz - 45 seconds ago